Select agent

Sitero Launches Biosafety Advisory Board, Naming Renowned Experts to Provide Guidance on Biosafety Compliance

Retrieved on: 
Tuesday, January 10, 2023

MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.

Key Points: 
  • MIAMI, Jan. 10, 2023 /PRNewswire/ -- Sitero has launched a first-of-its kind Biosafety Advisory Board and named several renowned biosafety experts as inaugural board members.
  • The board will advise Sitero on its biosafety services, helping ensure that the company provides industry-leading support for biosafety compliance.
  • The Sitero Biosafety Advisory board is the latest investment that Sitero is making in their Biosafety and IBC offerings due to their recent and expected continued growth in the space.
  • "Their efforts will be instrumental in delivering best practices in biosafety to inform our work at Sitero and advance the biosafety profession."

Sitero Celebrates National Biosafety Month With the Launch of Biosafety Consulting Services

Retrieved on: 
Tuesday, October 4, 2022

Sitero provides a full suite of offerings to customers, ranging from full-spectrum biosafety programs to bespoke services that supplement customers' in-house capabilities and allow them to focus on their highest priority.

Key Points: 
  • Sitero provides a full suite of offerings to customers, ranging from full-spectrum biosafety programs to bespoke services that supplement customers' in-house capabilities and allow them to focus on their highest priority.
  • While Sitero offers services such as training, program reviews and compliance audits, they have the biosafety expertise and technology-enabled solutions to build a flexible offering to meet any client's needs.
  • "We are excited to be celebrating Biosafety month with the launch of Sitero's Biosafety Consulting services," said, Dr. Sarah Ziegler, VP of Biosafety at Sitero.
  • Dr. Ziegler is responsible for leading the Biosafety and IBC services at Sitero.

Celsion Corporation Advances Proof of Concept to Non-human Primate Challenge Study Against SARS-CoV-2 with In-Process Vaccine Candidate

Retrieved on: 
Monday, January 31, 2022

LAWRENCEVILLE, N.J., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation DNA-based vaccines, announces it has engaged BIOQUAL, Inc., a preclinical testing contract research organization, to conduct a non-human primate (NHP) challenge study with Celsion’s DNA-based approach for a SARS-CoV-2 vaccine. The NHP pilot study follows the generation of encouraging mouse data and will evaluate the Company’s lead vaccine formulations for safety, immunogenicity and protection against SARS-CoV-2.

Key Points: 
  • The NHP pilot study follows the generation of encouraging mouse data and will evaluate the Companys lead vaccine formulations for safety, immunogenicity and protection against SARS-CoV-2.
  • Celsions novel DNA-based vaccines have been based on a simple intramuscular injection that does not require viral encapsulation or special equipment for administration.
  • Over the past 14 months, Celsion has substantially expanded its vaccine competencies, resources and capabilities, reinforced with the addition of several key scientists skilled in immunology and vaccine development.
  • Celsion assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

GAP Solutions Awarded CDC's Center for Preparedness and Response BPA

Retrieved on: 
Tuesday, March 3, 2020

HERNDON, Va., March 3, 2020 /PRNewswire-PRWeb/ -- GAP Solutions, a leading provider of public health preparedness and response support to Health and Human Services (HHS) and the Federal Government, has been awarded a follow-on prime contract by the Centers for Disease Control and Prevention (CDC) Center for Preparedness and Response (CPR).

Key Points: 
  • HERNDON, Va., March 3, 2020 /PRNewswire-PRWeb/ -- GAP Solutions, a leading provider of public health preparedness and response support to Health and Human Services (HHS) and the Federal Government, has been awarded a follow-on prime contract by the Centers for Disease Control and Prevention (CDC) Center for Preparedness and Response (CPR).
  • Additionally, on February 11th GAP Solutions was awarded the first Task Order released on the BPA, a 5-year order to provide support and assistance to CPR's Division of Select Agents and Toxins (DSAT).
  • GAP Solutions is prepared to deliver rapid, flexible, and effective solutions to help CPR and its component divisions and offices deliver on their steady state and emergency response mission.
  • "GAP Solutions is proud to continue to support CDC and the CPR via a contract tailored to deliver preparedness, response, and recovery emergency support functions," said Greg Bice, GAP Solutions Vice President for Scientific and Technical Programs.

IHRC, Inc. scientist helps advance public health and law enforcement response to bioterror threats

Retrieved on: 
Wednesday, February 26, 2020

In 2020, he co-edited the 3rd edition of Microbial Forensics, published by Elsevier Academic Press, and co-authored four of the book's chapters.

Key Points: 
  • In 2020, he co-edited the 3rd edition of Microbial Forensics, published by Elsevier Academic Press, and co-authored four of the book's chapters.
  • Most recently, he served as a senior advisor for the Division of Select Agents and Toxins in the Office of Public Health Preparedness and Response.
  • Dr. Morse received a Ph.D. in microbiology from the University of North Carolina School of Public Health in Chapel Hill, NC.
  • IHRC offers a robust profile of services spanning the areas of science and health, information management, management consulting, bioinformatics, and global health.